Fig. 5From: Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s diseaseHistopathological changes in the cerebral cortex of experimental group; NC: Normal control; HPD: Disease control; STD: Standard control; ALE: Albizia lebbeck (L.) extract; 100, 200 & 300: dose levels in mg/kgBack to article page